USA - NYSE:USB - US9029733048 - Common Stock
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 28.18B | 27.34B | 28.01B | 24.18B | 22.72B | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | 16.51B | 16.29B | 17.40B | 14.73B | 12.49B | |||
| Non Interest Income | 11.67B | 11.05B | 10.62B | 9.46B | 10.23B | |||
| Loan Loss Provision | 2.17B | 2.24B | 2.27B | 1.98B | -1.17B | |||
| Net Interest Income after Provision | 14.34B | 14.05B | 15.12B | 12.75B | 13.67B | |||
| Non Interest Expense | -16.92B | -17.19B | -18.87B | -14.91B | -13.73B | |||
| Minority Interest Expense | -27.00M | -30.00M | -29.00M | -13.00M | -22.00M | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | null | null | null | null | null | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | null | null | null | null | null | |||
| Operating Income | null | null | null | null | null | |||
| Interest Income/Expense | null | null | null | null | null | |||
| Other Income/Expense | null | null | null | null | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | 9.09B | 7.91B | 6.87B | 7.30B | 10.17B | |||
| Income Tax | 1.88B | 1.58B | 1.41B | 1.46B | 2.18B | |||
| Net Income | 6.81B | 5.91B | 5.05B | 5.50B | 7.61B | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 4.37 | 3.79 | 3.27 | 3.69 | 5.1 | |||
| Non GAAP EPS | 4.430000000000001 | 3.98 | 4.32 | 4.46 | 5.1000000000000005 | |||
| Statistics | ||||||||
| Profit Margin | 24.16% | 21.62% | 18.03% | 22.75% | 33.47% | |||
All data in USD